Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fujifilm Diosynth Biotechnologies USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014266
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fujifilm Diosynth Biotechnologies USA Inc (Fujifilm Diosynth), a subsidiary of Fujifilm Corp, is a contract development and manufacturing organization that develops therapeutic products, biologics and vaccines. The organization also develops processes for molecules expressed through fermentation, cell culture systems, insect cells and transgenic sources. It offers cell line strain development, process development, CGMP contract manufacturing, and other services. Fujifilm Diosynth’s activities include system development of mammalian, yeast, insect systems, microbial, viral vectors and virus replication host platforms. The organization serves biopharmaceutical industries in the US and the UK. Fujifilm Diosynth is headquartered in Morrisville, North Carolina, the US.

Fujifilm Diosynth Biotechnologies USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deal Details 9
Acquisition 9
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 9
Mitsubishi Acquires 20% Stake In Fujifilm Diosynth Biotechnologies U.S.A. And Fujifilm Diosynth Biotechnologies UK 10
Fujifilm Completes Acquisition Of Diosynth 11
Fujifilm Diosynth Biotechnologies USA Inc – Key Competitors 12
Fujifilm Diosynth Biotechnologies USA Inc – Key Employees 13
Fujifilm Diosynth Biotechnologies USA Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Recent Developments 15
Strategy And Business Planning 15
May 09, 2016: Fujifilm Diosynth Biotechnologies opens new laboratory facility in Research Triangle Park, NC 15
Product News 16
Oct 03, 2017: Bio-Ess Laboratories and FUJIFILM Diosynth Biotechnologies Find That Cell-Ess Media Supplement Improves Viral Production for Vaccine 16
Other Significant Developments 17
Mar 01, 2017: FUJIFILM Diosynth Biotechnologies Announces New Service Offering to Support Development and cGMP Monoclonal Antibody Production 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fujifilm Diosynth Biotechnologies USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 9
Mitsubishi Acquires 20% Stake In Fujifilm Diosynth Biotechnologies U.S.A. And Fujifilm Diosynth Biotechnologies UK 10
Fujifilm Completes Acquisition Of Diosynth 11
Fujifilm Diosynth Biotechnologies USA Inc, Key Competitors 12
Fujifilm Diosynth Biotechnologies USA Inc, Key Employees 13
Fujifilm Diosynth Biotechnologies USA Inc, Other Locations 14

★海外企業調査レポート[Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Gazprom Neft (SIBN):企業の財務・戦略的SWOT分析
    Gazprom Neft (SIBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Enercon GmbH:企業の戦略的SWOT分析
    Enercon GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Lantheus Medical Imaging Inc:製品パイプライン分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • ProSiebenSat.1 Media AG (PSM):企業の財務・戦略的SWOT分析
    ProSiebenSat.1 Media AG (PSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • YaSheng Group Ltd (HERB):企業の財務・戦略的SWOT分析
    Summary YaSheng Group Ltd (YaSheng) is a manufacturer of agriculture and package based products. The company operates through livestock, agriculture and biotechnology segments. YaSheng cultivates, processes, markets and distributes various food and agro-by products including field crops, fruits, veg …
  • Hsh Nordbank Private Banking
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cleveland-Cliffs Inc:企業のM&A・事業提携・投資動向
    Cleveland-Cliffs Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cleveland-Cliffs Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Astellas Pharma Inc (4503):企業の財務・戦略的SWOT分析
    Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fauji Fertilizer Co Ltd (FFC):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Co Ltd (FFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sumitomo Electric Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nemus Bioscience Inc (NMUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • DHL International GmbH:企業の戦略的SWOT分析
    DHL International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ryanair Holdings Plc (RY4C):企業の財務・戦略的SWOT分析
    Ryanair Holdings Plc (RY4C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mahle GmbH:企業の戦略・SWOT・財務情報
    Mahle GmbH - Strategy, SWOT and Corporate Finance Report Summary Mahle GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hindalco Industries Ltd:企業の戦略・SWOT・財務情報
    Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Solon Eiendom ASA (SOLON):企業の財務・戦略的SWOT分析
    Solon Eiendom ASA (SOLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Enerplus Corp (ERF):石油・ガス:M&Aディール及び事業提携情報
    Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resource properties for the production of crude oil, light and heavy oil, natural gas, shallow ga …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Vestas Wind Systems A/S:企業の戦略・SWOT・財務情報
    Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report Summary Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆